home-header-beeld01.jpg
Home slider beeld 02
Lab website TS Essen.jpg

    In cancer, infection and inflammation, the immune system’s function is dysregulated, contributing to disease pathology. As part of this process, instead of fighting disease, immune cells may even suppress beneficial immune responses and increase pathology. Despite their pathophysiological importance, the identity and biology of the so called myeloid regulatory cells (MRCs) is poorly understood. 

    Mye-EUNITER:

    European Network of Investigators Triggering Exploratory Research on Myeloid Regulatory Cells

     

    Action Chair: Sven Brandau (DE)

    Vice-Chair: Annabel Valledor (ES)

    Symposium-in-Writing

    The COST Action Mye-EUNITER is proud to announce the first publication of a Symposium-in-Writing in Cancer Immunology, Immunotherapy which has been written by its members:

    How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions. Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA, Brandau S. Cancer Immunol Immunother. 2018 May 21. doi: 10.1007/s00262-018-2170-8

    © Springer-Verlag GmbH Germany, part of Springer Nature 2018

    1st review.jpg
    Tweets